Sprinter vs Skater Coordination Synergy Training for Balance and Coordination in Chronic Stroke (NCT07658495) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Sprinter vs Skater Coordination Synergy Training for Balance and Coordination in Chronic Stroke
Pakistan22 participantsStarted 2026-02-01
Plain-language summary
This study compares two types of coordinative locomotor training - the sprinter coordination synergy and the skater coordination synergy - to improve balance and coordination in people with chronic stroke (more than six months after stroke). Twenty two participants will be randomly assigned to receive either sprinter-based or skater-based training for 30 minutes per session, three times per week, for four weeks. Balance will be measured using the Berg Balance Scale and Functional Reach Test. Coordination and functional mobility will be measured using the Timed Up and Go test. This study aims to determine which coordination synergy produces greater improvements, which may help physiotherapists choose more effective treatments for stroke survivors in Pakistan.
Who can participate
Age range
30 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Physician-diagnosed ischemic or hemorrhagic stroke
* Age between 30 and 60 years, inclusive
* Both male and female participants
* Time since stroke onset: 6 months or more (chronic stage)
* Able to stand or walk independently for at least 10 meters (with or without assistive device)
* Able to follow verbal instructions (Mini-Mental State Examination score ≥ 24 or equivalent clinical judgment)
* Able to provide informed consent
Exclusion Criteria:
* Visual impairment that interferes with movement coordination
* Hearing deficit that prevents following instructions
* Vestibular dysfunction affecting balance
* Orthopedic disorders (fracture, joint deformity, severe arthritis, joint replacement) limiting movement
* Other neurological disorders besides stroke (Parkinson's disease, multiple sclerosis, peripheral neuropathy)
* Contraindication to exercise as advised by physician
* Participation in another interventional rehabilitation study concurrently
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Balance as Measured by the Berg Balance Scale
Timeframe: Baseline (week 0, before first intervention session) and post-intervention (week 4, within 48 hours after the final intervention session)
2
Change in Dynamic Balance as Measured by the Functional Reach Test
Timeframe: Baseline (week 0, before first intervention session) and post-intervention (week 4, within 48 hours after the final intervention session)
3
Change in Functional Mobility and Coordination as Measured by the Timed Up and Go Test
Timeframe: Baseline (week 0, before first intervention session) and post-intervention (week 4, within 48 hours after the final intervention session)